{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3385, 
        3399
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4276, 
        4290
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4449, 
        4463
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4739, 
        4762
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3161, 
        3188
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3096, 
        3101
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3138, 
        3142
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        525, 
        554
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2572, 
        2598
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2866, 
        2892
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3889, 
        3912
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4110, 
        4133
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4193, 
        4216
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4712, 
        4735
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4257, 
        4265
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4430, 
        4438
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3421, 
        3434
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4292, 
        4305
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4465, 
        4478
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3462, 
        3463
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4306, 
        4307
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4479, 
        4480
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3871, 
        3887
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4092, 
        4108
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4175, 
        4191
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4266, 
        4275
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4439, 
        4448
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4694, 
        4710
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2613, 
        2623
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2644, 
        2653
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2674, 
        2684
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2705, 
        2714
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2735, 
        2743
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2764, 
        2773
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2915, 
        2925
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2946, 
        2955
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2976, 
        2986
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3007, 
        3016
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3037, 
        3045
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3066, 
        3075
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3853, 
        3863
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3937, 
        3946
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4074, 
        4084
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4158, 
        4167
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4241, 
        4249
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4413, 
        4422
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2600, 
        2602
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2631, 
        2633
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2661, 
        2663
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2692, 
        2694
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2722, 
        2724
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2751, 
        2753
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2781, 
        2782
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2823, 
        2825
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2895, 
        2897
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2926, 
        2928
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2956, 
        2958
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2987, 
        2989
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3017, 
        3019
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3046, 
        3048
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3076, 
        3078
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3118, 
        3120
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3916, 
        3918
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4053, 
        4055
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4137, 
        4139
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4392, 
        4394
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4567, 
        4569
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4662, 
        4664
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 8^9999^MOH|PIMS|CCO|201605061638|76952CCF1B18CE806172EBBAE995DF34B0E45073|ORU^R01|PIMS-OUT.1.184018|P|2.5|\nPID|1||999999^^^^CMR^HOSPITAL 8&9999&MOH~999999^^^^MRN^HOSPITAL 8&9999&MOH~9999999999&JA&ON^^^^JHN||XXXXX^XXXXXXX^XXXXXX^^^||99999999|M|||999-9999 XXXX XXXXX XX X^^XXXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|\nOBR|1||16:S6559|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160505|||71144^XXXXXXXXXXXX^XXXXX^^^^||||||||||||20160506|||F|||||||999999^XXXXXXXX^XXXXXX^^^^|\n\n\n\n\n\n\n\nPath report.gross description\n\n\nA. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 1RB'. The specimen consists of 2\ncores of pale tan tissue measuring 18 and 15 x 1.0 x 1.0 mm. The specimen\nis submitted in toto in cassette A1.\n \nB. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 2RM'. The specimen consists of 2\ncores of pale tan tissue measuring 15 and 10 x 1.0 x 1.0 mm. The specimen\nis submitted in toto in cassette B1.\n \nC. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 3RA'. The specimen consists of a\nsingle core of pale tan tissue measuring 15 x 1.0 x 1.0 mm which is\nsubmitted in toto in cassette C1.\n \nD. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 4LB'. The specimen consists of 2\ncores of pale tan tissue measuring 17 and 15 x 1.0 x 1.0 mm. The specimen\nis submitted in toto in cassette D1.\n \nE. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 5LM'. The specimen consists of 2\ncores of pale tan tissue measuring 19 and 19 x 1.0 x 1.0 mm. The specimen\nis submitted in toto in cassette E1.\n \nF. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 6LA'. The specimen consists of a\nsingle core of pale tan tissue measuring 20 x 1.0 x 1.0 mm which is\nsubmitted in toto in cassette F1.\n \nG. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 7RTZ'. The specimen consists of a\nsingle core of pale tan tissue measuring 16 x 1.0 x 1.0 mm which is\nsubmitted in toto in cassette G1.\n \nH. The specimen is received in 10% buffered formalin. The container is\nlabeled 'Smith, Richard, unit #102411, 8LTZ'. The specimen consists of a\nsingle core of pale tan tissue measuring 18 x 1.0 x 1.0 mm which is\nsubmitted in toto in cassette H1.\n\n\n\nPath report.site of origin\n\nA: Prostate, right base biopsy\nB: Prostate, right mid biopsy\nC: Prostate, right apex biopsy\nD: Prostate, left base biopsy\nE: Prostate, left mid biopsy\nF: Prostate, left apex biopsy\nG: Prostate, right transition zone biopsy\nH: Prostate, left transition zone biopsy\n\n\nPath report.site of origin\n\n\nA. Prostate biopsy, right base\nB. Prostate biopsy, right mid\nC. Prostate biopsy, right apex\nD. Prostate biopsy, left base\nE. Prostate biopsy, left mid\nF. Prostate biopsy, left apex\nG. Prostate biopsy, right transition zone\nH. Prostate biopsy, left transition zone\n\n\nPath report.final diagnosis\n\n================================================================================\nCARCINOMA SUMMARY:\n________________________________________________________________________________\nTumour type - adenocarcinoma, conventional type\n \nGleason score (primary, secondary)     - 6(3,3)\ntertiary pattern              - N/A\n% pattern 4, 5               - N/A\n# sites involved              - 2/8\npositive cores               - 2/12\noverall % tissue involved          - 3-5%\nperineural invasion             - Not present\nperiprostatic fat invasion         - Not present\n________________________________________________________________________________\n \nA. BIOPSY, PROSTATE (RIGHT BASE)\n \n  - PROSTATIC TISSUE, NEGATIVE FOR MALIGNANCY.\n \nB. BIOPSY, PROSTATE (RIGHT MID)\n \n  - FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIA, HIGH GRADE WITH ATYPICAL SMALL\n   GLANDS (PIN-ASAP). \n \nC. BIOPSY, PROSTATE (RIGHT APEX)\n \n  - PROSTATIC TISSUE, NEGATIVE FOR MALIGNANCY.\n \nD. BIOPSY, PROSTATE (LEFT BASE)\n \n  - PROSTATIC TISSUE, NEGATIVE FOR MALIGNANCY.\n \nE. BIOPSY, PROSTATE (LEFT MID)\n \n  - INVASIVE PROSTATIC ADENOCARCINOMA; GLEASON SCORE 6/10 (PRIMARY 3,\n   SECONDARY 3); 1/2 CORES INVOLVED; ABOUT 15% TISSUE INVOLVEMENT.\n \nF. BIOPSY, PROSTATE (LEFT APEX)\n \n  - INVASIVE PROSTATIC ADENOCARCINOMA; GLEASON SCORE 6/10 (PRIMARY 3,\n   SECONDARY 3); 1/1 CORE INVOLVED; ABOUT 30-35% TISSUE INVOLVEMENT.\n \nG. BIOPSY, PROSTATE (RTZ)\n \n  - FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN), HIGH GRADE.\n \nH. BIOPSY, PROSTATE (LTZ)\n \n  - PROSTATIC TISSUE, NEGATIVE FOR MALIGNANCY.\n\n\nPath report.relevant Hx\n\n\nTotal serum PSA: 5.8 ng/mL\nFree total PSA ratio: 0.08\nDRE Findings: Diagnosis study\nAntibiotics: Yes\nTX: 49.8\nAP: 34.0\nCC: 42.3\nVolume: 37.5\nPSA predicted: 4.5\n\n\n"
}